Hemogenyx Pharmaceuticals PLC on Monday said it completed a process qualification run.
The London-based biopharmaceutical company focused on treatments for deadly blood diseases said it successfully.
LONDON, UK / ACCESSWIRE / January 8, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), which is developing new therapies and treatments for blood diseases, is pleased to announce the successful completion of its Process Qualification ("PQ") run of the end-to-end process for the manufacture of HEMO-CAR-T cel.
Hemogenyx Pharmaceuticals (LON:HEMO) Stock Price Up 2.4% kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £534,375 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
88 Energy Ltd - Alaska-focused oil.